IsraCann Biosciences
  • Company
  • Project
  • Market
  • Investors
  • News
  • Contact
Get News Alerts

Month: May 2022

Isracann Biosciences Subsidiary Praesidio Health Submits NPNs to Health Canada

VANCOUVER, BC, — (May 19, 2022) – Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) a multi-faceted organization with a natural health medicine division in Canada and holdings in Israel, is pleased to announce that its wholly owned subsidiary Praesidio Health has completed the natural product number (NPN) submissions to Health Canada for...
19 May 2022 / Corporate News
Read More

Recent Posts

  • Isracann Biosciences Provides Bi-Weekly Default Status Report
    13 Oct 2022
    /
    Corporate News
  • Isracann Biosciences Announces Delay in Filing Annual Financial Statements
    29 Sep 2022
    /
    Corporate News
  • Isracann Bioscience Facilitated Genetics Arrive in Israel
    28 Sep 2022
    /
    Corporate News
  • Isracann Bioscience Facilitates Cannabis Genetics Shipment to Israel
    14 Sep 2022
    /
    Corporate News
  • Praesidio signs distribution agreement with Pure Integrative Pharmacy
    01 Sep 2022
    /
    Corporate News

Archives

  • October 2022
  • September 2022
  • August 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • October 2021
  • August 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • October 2020
  • September 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • January 2019
  • November 2018
  • September 2018

Categories

  • Corporate News
  • Global Cannabis News

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
Contact Us
© 2023 Isracann BioSciences
  • Privacy Policy
  • Terms of Use
  • Site Map

Stay up to date with IsraCann news & events